Cited by 327Health Systems, Economic Evaluations, Quality of LifeParkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatments

The EQ-5D---a generic quality of life measure---is a useful instrument to measure quality of life in patients with Parkinson's disease

Open access
Schrag, A.·2000·Journal of Neurology, Neurosurgery & Psychiatry

Abstract

OBJECTIVE: To test the feasibility and validity of the EQ-5D (a widely used generic (disease non-specific) quality of life (QoL) instrument which allows comparisons between different patient groups and the general population) to assess QoL in patients with Parkinson's disease. METHODS: All 124 patients with Parkinson's disease seen in a community based study on the prevalence of parkinsonism were asked to complete a QoL battery comprising the EQ-5D, the medical outcome study short form (SF-36), the PDQ-39, a disease specific instrument to assess QoL in PD, and the Beck depression inventory. A structured questionnaire interview and a complete neurological examination including the Hoehn and Yahr stage of illness scale, the Schwab and England disability scale, the motor section of the unified Parkinson's disease rating scale (UPDRS), and the mini mental state examination (MMSE) were performed on the same day. RESULTS: The response rate was 78% and the completion rate of the EQ-5D among responders was 96%. The EQ-5D summary index correlated strongly with the PDQ-39 (r=-0.75, p<0.0001) as well as the physical score of the SF-36 (r=0.61, p<0.0001). There was a significant correlation of the EQ-5D summary index with disease severity, as measured by the Hoehn and Yahr stage of illness, the Schwab and England disability scale, the motor section of the UPDRS, and the depression score. The EQ-5D summary index also distinguished between patients with and without depression, falls, postural instability, cognitive impairment hallucinations, and those with deterioration of health over the previous year. CONCLUSION: The EQ-5D is a feasible and valid instrument to measure QoL in Parkinson's disease and reflects the severity and complications of the disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jnnp.69.1.67

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

3 of the 37 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. on July 16, 2023 by guest. Protected by copyright. http://jnnp.bmj.com/ J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.69.1.67 on 1 July 2000. Downloaded from
  2. Schwab RS, England AC. Projection technique for evaluat- ing surgery in Parkinson's disease. In: Gillingham FJ, Don- aldson IML, eds. Third Symposium on Parkinson's disease. Edinburgh: Livingstone, 1969:152-7.

Cited by

Sorted by citations

Authors
Schrag, A.
Affiliations
National Hospital for Neurology and Neurosurgery (GB)
Corresponding author
Schrag, A.
Venue
Journal of Neurology, Neurosurgery & Psychiatry
Publisher
BMJ
Published
2000-07-01
Volume
69
Issue
1
Pages
67-73
ISSN
0022-3050 (ISSN-L)
OpenAlex
W2135640360
Cited by
327
References
37
Citations by year
2026: 10 · 2025: 5 · 2024: 8 · 2023: 11 · 2022: 16 · 2021: 13 · 2020: 13 · 2019: 12 · 2018: 10 · 2017: 14 · 2016: 8 · 2015: 17 · 2014: 19 · 2013: 23 · 2012: 12
FWCI
19.84
Type
journal article
Language
en
Open access
Locations
  • Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Neurology › Neurological disorders and treatments
Keywords
EQ-5D, Parkinson's disease, quality of life, assessment validity, PDQ-39, SF-36, depression, disease severity, disability, falls, postural instability, cognitive impairment, hallucinations
MeSH terms
Activities of Daily Living, Adult, Aged, Aged, 80 and over, Feasibility Studies, Female, Humans, Male, Mental Status Schedule, Middle Aged, Parkinson Disease, Quality of Life, Sick Role, Reproducibility of Results, Sickness Impact Profile

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review